bpc-157 fda compounding category Peptide Review 2026: What This Big Shift Means HIMS jumps more than 7%

HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer FDA Compliance for Peptide Therapy and BPC 157 Holt Law FDA Advisory Committee Recommends Adding BPC 157 to Compounding List American Med Spa Association FDA panel votes to place popular peptide BPC 157 on compounding list Reuters Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest

SKU: 9948999733 · From www.ohotnichi-sezoni.com